Egis Pharmaceuticals

Egis Pharmaceuticals is a well-established, commercial-stage Hungarian pharmaceutical company with a century-long history, primarily focused on generic drugs. It maintains a fully integrated operation spanning R&D, manufacturing, and global sales, with a significant footprint in over 100 countries. The company emphasizes innovation within its generic-focused strategy, as evidenced by recent R&D awards, and is actively investing in manufacturing capacity expansion in Hungary. It is recognized as a Top Employer, indicating a strong corporate culture.

Integrated generic pharmaceutical development and manufacturing platform encompassing API synthesis, formulation development, analytical controls, and bioequivalence testing, with a focus on complex generics and value-added products.

Egis competes in the highly fragmented global generic pharmaceuticals market against large multinational firms (e.g., Teva, Viatris, Sandoz) and low-cost Asian manufacturers. Its competitive edge lies in its fully integrated model, European quality standards, focus on complex products, and strong position in Central and Eastern European markets.